6 Hrs
Source:
اليوم السابع
Most Read
Source: اليوم السابع
6 Hrsاليوم السابع
Source: اليوم السابع
6 HrsReady to play
Ready to play
The Egyptian Drug Authority has focused on establishing a new drug pricing system that balances patients' rights with the protection of pharmaceutical security. This system uses a formula based on 60% exchange rate, 30% inflation, and 10% interest rate. It sets pricing rules for original medicines through a reference list of 15 countries, and employs special mechanisms for pricing high-cost medications based on their therapeutic value, with biannual reviews to keep up with economic changes. The decision also specifies profit margins for distributors and pharmacists, and requires that medicines are not sold at prices outside the approved range. The system aims to protect domestically manufactured medicines for five years, with mechanisms to reduce prices when alternatives are available, and facilitates the collection of expired medicines, with a return rate not exceeding 3%.
Notice: This Is an AI-Generated Summary
Comments (0)